Magnetic Resonance Imaging (MRI), and emerging Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET)/MRI, can be used to detect and locate prostate cancer. The accuracy of this method can be validated by comparing post-prostatectomy histopathology information to MRI and PET image data with the help of a custom prostate-sectioning device. This study is aimed at addressing sectioning device limitations proposed by previous studies and at developing a three-dimensional (3D) comparison method for MRI data and post-prostatectomy prostate geometries.
This abstract and the presentation materials are available to members only; a login is required.